Clinical Trial WisdomCard™
BG-12 Pill Shows Promise in Suppressing Multiple Sclerosis Relapses - NYTimes.com
nytimes.com — “Clinical trials indicate that BG-12, developed by Biogen Idec, may be safer and more effective than existing treatments for patients in the early stages of the disease.” View full resource at nytimes.com
Most Recently Shared on September 20, 2012 at 6:02 pm By:
Oral Medication Promising in Treating Early-Stage MS: http://t.co/yqZW5OQ3 #MS #multiplesclerosis
Hayfever Vaccine Study Raises Hopes For New Allergy Treatment As Clinical Trial Is Launched
medicalnewstoday.com — “Researchers are developing a new vaccine for hayfever which could be more effective, less invasive for patients and less expensive than vaccines already available to patients within the NHS.” View full resource at medicalnewstoday.com
Most Recently Shared on September 12, 2012 at 8:05 am By:
Hayfever Vaccine Study Raises Hopes For New Allergy Treatment As Clinical Trial Is Launched http://t.co/WpbHuID8 #vaccines #immunesystem
D-Fortified Milk Curbs Colds in Kids
medpagetoday.com — “Drinking milk fortified with vitamin D decreased winter colds among kids deficient in the vitamin, a clinical trial in Mongolia showed.” View full resource at medpagetoday.com
Most Recently Shared on August 20, 2012 at 3:00 pm By:
Vitamin D D-Fortified Milk Curbs Colds in Kids http://t.co/sGaZxBva
Hookworm Infections Cured In Hamster Model
medicalnewstoday.com — “A drug candidate that is nearing clinical trials against a Latin American parasite is showing additional promise as a cure for hookworm, one of the most widespread and insidious parasites afflicti” View full resource at medicalnewstoday.com
Most Recently Shared on July 5, 2012 at 8:05 am By:
Hookworm Infections Cured In Hamster Model http://t.co/WdVw9qlG #blood #hematology
Inovio SynCon avian influenza vaccine demonstrates broad coverage
news-medical.net — “Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.” View full resource at news-medical.net
Most Recently Shared on May 17, 2012 at 2:05 pm By:
Bird Flu News: Inovio SynCon avian influenza vaccine demonstrates broad coverage: Inovio Pharmaceuticals, Inc. a... http://t.co/Sxj6FnIz
Experimental drug delays MS progression - chicagotribune.com
chicagotribune.com — “A new experimental drug delays progression of relapsing-remitting multiple sclerosis in clinical trial.” View full resource at chicagotribune.com
Most Recently Shared on April 19, 2012 at 4:58 am By:
Phase 2 trials of ONO-4641 reduce lesion growth by as much as 92% - Chicago Tribune: Phase 2 trials of ONO... http://t.co/YKzlFmgb #drug
In Sinusitis, Antibiotics Are as Effective as Placebos, Study Finds | Your Unified Airway: keeping it healthy | Scoop.it
scoop.it — “A new clinical trial found that a placebo worked just as well as the antibiotic amoxicillin in treating the runny nose, sneezing, cough, headache and other symptoms of sinusitis.” View full resource at scoop.it
Most Recently Shared on February 26, 2012 at 2:15 pm By:
In Sinusitis, Antibiotics Are as Effective as Placebos, Study Finds | @scoopit via @moicall http://t.co/VKeJnlVD
Athersys, University Hospitals partner for clinical trials of MultiStem for stroke
medcitynews.com — “Athersys (NASDAQ:ATHX), which is developing stem cell treatments, will work with University Hospitals Cleveland on a phase 2 clinical trial for ischemic stroke.” View full resource at medcitynews.com
Most Recently Shared on February 23, 2012 at 3:40 pm By:
RT @medcitynews: Athersys, University Hospitals partner for clinical trials of MultiStem for stroke http://t.co/1PbHc1ee
: The Michael J. Fox Foundation
michaeljfox.org — “For The Michael J. Fox Foundation, there is one clear measure of success: delivering patients better treatments and, ultimately, a cure for Parkinson's disease.” View full resource at michaeljfox.org
Most Recently Shared on December 3, 2011 at 6:48 pm By:
Meet Tom Peplinski and other #100Husbands, men participating in #Parkinsons clinical trials http://t.co/VMe6Kiur
Dark chocolate/cocoa effective for cholesterol improvements: Meta-analysis
nutraingredients-usa.com — “Consuming polyphenol-rich dark chocolate or cocoa products may reduce total and LD cholesterol levels, but has no effect on HDL levels, according to a meta-analysis of 10 clinical trials.” View full resource at nutraingredients-usa.com
Most Recently Shared on August 23, 2011 at 4:34 pm By:
More evidence of the positive effects of dark chocolate on cholesterol: http://t.co/fpA5WXv That's DARK chocolate.
Promising results of Phase I diabetes trial
sciencedaily.com — “Medical researchers report promising results of the Phase I clinical trial of the generic drug BCG (bacillus Calmette-Guerin) to treat advanced type I diabetes.” View full resource at sciencedaily.com
Most Recently Shared on August 17, 2011 at 8:21 pm By:
Promising results from a Phase I trial using the BCG vaccine in patients with Type I diabetes: http://t.co/MolkbsZ
Mayo Clinic - Stopping Clinical Trials Early Often Exaggerates Treatment Effects
mayoclinic.org — “Mayo Clinic - Stopping Clinical Trials Early Often Exaggerates Treatment Effects” View full resource at mayoclinic.org
Most Recently Shared on March 23, 2010 at 9:19 pm By:
Stopping Clinical Trials Early Often Exaggerates Treatment Effects: An international study of nearly 100 clinical ... http://bit.ly/d8NsAG
Aveo jumps into IPO game with plans to raise $86M - FierceBiotech
fiercebiotech.com — “With an impressive list of pharma partners by its side, solid backing by VC investors and a late-stage clinical trial underway in renal cell cancer, Aveo Pharmaceuticals says it's time to go public. Read more...” View full resource at fiercebiotech.com
Most Recently Shared on December 17, 2009 at 4:06 pm By:
Aveo jumps into IPO game with plans to raise $86M. http://is.gd/5rmW2
Halozyme Begins Clinical Trial To Compare Three Insulin Analogs And Provides Update On Ultrafast Insulin Program
medicalnewstoday.com — “Halozyme therapeutics, inc. (nasdaq:halo) announced the commencement of a phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered wit” View full resource at medicalnewstoday.com
Most Recently Shared on September 30, 2009 at 10:42 am By:
Halozyme Begins Clinical Trial To Compare Three Insulin Analogs And Provides Update On Ultrafast Insulin Progra.. http://bit.ly/mUOpR

